Form 4: Disc Medicine Executive William Jacob Savage Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., sold 1,500 shares of common stock at a price of $47.41 per share on September 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 16, 2024, William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), sold 1,500 shares of the company's common stock.
- The sale was executed at a price of $47.41 per share.
- Following the transaction, Savage directly owns 40,405 shares of Disc Medicine, Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on April 12, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting an insider stock sale under a pre-arranged trading plan, suggesting a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives and their potential views on the company's stock.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| April 12, 2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| September 16, 2024 | Date of the stock sale transaction. |
| September 18, 2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.